NASDAQ
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has a fcf yield of -17.54% as of Friday, May 29, 2026. This represents a 339.26% decrease compared to its 12-month average of -3.99%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.